Osteoarthritis year 2010 in review: Pathomechanisms

Osteoarthritis and Cartilage

Volumn 19, Issue 4, 2011, Pages 338-341

  van den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autophagy; Cartilage destruction; Chondrocytes; DDR 2; HIF 2 ; Metalloproteinases; OA cartilage pathology; S100A8; Syndecan 4; TGF

Indexed keywords

AGGRECANASE 2; CALGRANULIN A; COLLAGEN TYPE 2; COLLAGENASE 3; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SYNDECAN 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; AUTOPHAGY; CARTILAGE CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALGRANULIN A; CALGRANULIN B; CARTILAGE, ARTICULAR; HUMANS; MATRIX METALLOPROTEINASE 13; MICE; OSTEOARTHRITIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SYNDECAN-4; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952814836     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2011.01.022     Document Type: Review

References (25)

1. Clockaerts S., Bastiaansen-Jenniskens Y.M., Runhaar J., van Osch G.J., van Offel J.F., Verhaar J.A., et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010, 18:876-882.
2. Yang S., Kim J., Ryu J.H., Oh H., Chun C.H., Kim B.J., et al. Hypoxia inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010, 16:687-694.
3. Saito T., Fukai A., Mabuchi A., Ikeda T., Yano F., Ohba S., et al. Transcriptional regulation of endochondral ossification by HIF-2α during skeletal growth and osteoarthritis development. Nat Med 2010, 16:678-686.
4. Wang J., Gardner B.M., Lu Q., Rodova M., Woodbury B.G., Yost J.G., et al. Transcription factor NFAT1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes. J Pathol 2009, 219:163-172.
5. Carames B., Taniguchi N., Otsuki S., Blanco F.J., Lotz M. Autophagy is a protective mechanism in normal cartilage and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum 2010, 62:791-801.
6. Bohensky J., Terkhorn S.P., Freeman T.A., Adams C.S., Garcia J.A., Shapiro I.M., et al. Regulation of autophagy in human and murine cartilage: HIF2 suppresses chondrocyte autophagy. Arthritis Rheum 2009, 60:1406-1415.
7. Neuhold L.A., Killar L., Zhao W., Sung M.L., Warner L., Kulik, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001, 107:35-44.
8. Little C.B., Barai A., Burkhardt D., Smith S.M., Fosang A.J., Werb Z., et al. Murine metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009, 60:3723-3733.
9. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
10. Xu L., Servais J., Polur I., Kim D., Lee P.L., Chung K., et al. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum 2010, 62:2736-2744.
11. Echtermeyer F., Bertrand J., Dreier R., Meinecke I., Neugebauer K., Fuerst M., et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009, 15:1072-1077.
12. Matsui Y., Iwasaki N., Kon S., Takahashi D., Morimoto J., Matsui Y., et al. Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 2009, 60:2362-2371.
13. Kon S., Ikesue M., Kimura C., Aoki M., Nakayama Y., Saito Y., et al. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J exp Med 2008, 205:25-33.
14. Van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. OA-like changes in the murine knee joint resulting from intra-articular TGFβ injections. Osteoarthritis Cartilage 2000, 8:25-33.
15. Scharstuhl A., Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., van den Berg W.B. Inhibition of endogenous TGFβ during experimental OA prevents osteophyte formation and impairs cartilage repair. J Immunol 2002, 169:507-514.
16. Blaney Davidson E.N., Remst D.F., Vitters E.L., van Beuningen H.M., Blom A.B., Goumans M.J., et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009, 182:7937-7945.
17. Li T.F., Gao L., Sheu T.J., Sampson E.R., Flick L.M., Konttinen Y.T., et al. Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring TGFβ-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis. Arthritis Rheum 2010, 62:2359-2369.
18. Valdes A.M., Spector T.D., Tamm A., Kisand K., Doherty S.A., Dennison E.M., et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 2010, 62:2347-2352.
19. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., et al. Mrp8 and Mrp14 are endogenous activators of TLR4, promoting lethal, endotoxin-induced shock. Nat Med 2007, 13:1042-1049.
20. Van lent P.L., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Volgl T., et al. Myeloid related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen induced arthritis. Ann Rheum Dis 2008, 67:1750-1758.
21. Van Lent P.L., Grevers L.C., Blom A.B., Arntz O.J., van de Loo F.A., van der Kraan P.M., et al. Simulation of chrondrocyte mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 2008, 58:3776-3787.
22. Zreiqat H., Belluoccio D., Smith M.M., Wilson R., Rowley L.A., Jones K., et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther 2010, 12. R16.
23. Zhu M., Tang D., Wu Q., Hao S., Chen M., Xie C., et al. Activation of β-catenin signaling in articular chondrocytes leads to OA-like phenotype in adult β-catenin conditional activation mice. J Bone Min Res 2009, 24:12-21.
24. Wu Q., Zhu M., Rosier R.N., Zuscik M.J., O'Keefe R.J., Chen D. Beta-catenin, cartilage and osteoarthritis. Ann N Y Acad Sci 2010, 1192:344-350.
25. Blom A.B., van Lent P.L., van der Kraan P.M., van den Berg W.B. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. Curr Drug Targets 2010, 11:620-629.